Back to search results
NCT07073937

Three Year Outcomes of Combined Hydrus Microstent With iTrack Canaloplasty

Enrolling by Invitation
Not specifiedAges 18+Observational
University of Utah
~100 participants
Updated 2026-01-09 on ClinicalTrials.gov
What's tested:Retrospective chart review

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Percentage of surgical success at three years.
Measured over From baseline to three years post-surgery

Conditions

Glaucoma, Open Angle
MIGS
Minimally Invasive Glaucoma Surgery
Canaloplasty
Intraocular Pressure (IOP)
Cataract Surgery
Surgical Technique
Minimally Invasive Surgical Technique
Glaucoma

Explore related trials

CataractOpen Angle Glaucoma

Where it's being run

1 sites across 1 states
Utah1

Study leadership

  • Craig Chaya, MD · PRINCIPAL_INVESTIGATOR · University of Utah John A. Moran Eye Center

Who to contact

This trial hasn't published a contact. View it on ClinicalTrials.gov

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Patients with open angle glaucoma (mild, moderate or severe as defined below) who have undergone combined Hydrus and 360 degree canaloplasty with concomitant cataract surgery with at least 3-year follow-up data
Mild: Definite optic disc, RNFL, or macular imaging abnormalities consistent with glaucoma and a normal visual field as tested with standard automated perimetry (SAP)
Moderate: Definite optic disc, RNFL, or macular imaging abnormalities consistent with glaucoma, and visual field abnormalities in one hemifield that are not within 5 degrees of fixation as tested with SAP
Severe: Definite optic disc, RNFL, or macular imaging abnormalities consistent with glaucoma, and visual field abnormalities in both hemifields and/or loss within 5 degrees of fixation in at least one hemifield as tested with standard automated perimetry (SAP)
Patients who have had prior selective laser trabeculoplasty (SLT) are allowed

Exclusion

Prior corneal graft (penetrating Keratoplasty \[PKP\], deep anterior lamellar keratoplasty \[DALK\], Descemet's Stripping Automated Endothelial Keratoplasty \[DSAEK\], Descemet membrane endothelial keratoplasty \[DMEK\]) \& refractive surgery
Prior retinal surgery
Prior MIGS or incisional glaucoma surgery
Angle closure glaucoma and other secondary glaucoma

What this trial measures

  • Percentage of surgical success at three years.From baseline to three years post-surgery

    Surgical success is defined as a decrease of one or more glaucoma medications from baseline without an increase in medicated intraocular pressure (IOP).